Please login (Members) to view content or
(Nonmembers) this article.
No votes yet
Foreign Exchange

The Challenge of Rare Cancers in Current and Advancing Treatment

Nancy G. Houlihan
ONF 2015, 42(5), 566-567 DOI: 10.1188/15.ONF.566-567

The term rare cancers is relatively new in oncology, with significant presence in cancer literature occurring only since the early 2000s. Epidemiologic studies in Europe and the United States show that rare cancers account for about 25% of adult cancers. However, rare cancer types have been traditionally understudied, with an associated lack of progress in survival and challenges in decision making for patients, physicians, and policy makers.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or